A Chronic Disorder in the Emergency Room: A Descriptive Analysis of Paroxysmal Atrial Fibrillation Cases Requiring Urgent Treatment

Petrit Bara¹, Sokol Myftiu¹ and Gentian Vyshka^2,

¹Department of Cardiology, University Hospital Center ‘Mother Theresa’, Faculty of Medicine, University of Medicine in Tirana, Albania

²Biomedical and Experimental Department, Faculty of Medicine, University of Medicine in Tirana, Albania

Cite this paper:
Petrit Bara, Sokol Myftiu and Gentian Vyshka. A Chronic Disorder in the Emergency Room: A Descriptive Analysis of Paroxysmal Atrial Fibrillation Cases Requiring Urgent Treatment. American Journal of Cardiovascular Disease Research. 2013; 1(1):16-19. doi: 10.12691/ajcdr-1-1-4

Abstract

Atrial fibrillation (AF) is the most frequent arrhythmia, and patients frequently visit emergency departments, where the condition might be diagnosed for the first time. An analysis of factors that might lead a chronic patient to seek urgent medical treatment is important, especially in terms of preventing long-term disability and morbidity. This is even truer for atrial fibrillations, whose complications have a known notoriety and are source of important mortality figures, mainly related to ischemic stroke or more serious consequential cardiac arrhythmias. We have studied paroxysmal AF cases treated during a period of two months in an emergency facility of the University Hospital Centre of Tirana, with 106 patients recruited sequentially in a prospective, open-label and descriptive study. Our data confirmed an important association between overweight and obesity and paroxysmal AF in general, since more than 80% of the patients suffering from this condition had a high body mass index. A thorough discussion of the data, confronted with much larger studies reported from several sources and available actually, is made at the end of the paper. The necessity to re-confirm findings through larger groups of study and through a multi-centre design is formulated.

Keywords:
atrial fibrillation emergency room non-valvular atrial fibrillation risk factors body-mass index

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population. Am J Cardiol. 2013 Jul 4.
[2]	Todaro MC, Choudhuri I, Belohlavek M, Jahangir A, Carerj S, Oreto L, Khandheria BK. New echocardiographic techniques for evaluation of left atrial mechanics. Eur Heart J Cardiovasc Imaging. 2012 Dec; 13(12):973-84.
[3]	Barrett TW, Self WH, Jenkins CA, Storrow AB, Heavrin BS, McNaughton CD, Collins SP, Goldberger JJ. Predictors of Regional Variations in Hospitalizations Following Emergency Department Visits for Atrial Fibrillation. Am J Cardiol. 2013 Aug 22.
[4]	Atzema CL, Austin PC, Miller E, Chong AS, Yun L, Dorian P. A Population-Based Description of Atrial Fibrillation in the Emergency Department, 2002 to 2010. Ann Emerg Med. 2013 Jun 26.
[5]	Atzema CL, Dorian P, Ivers NM, Chong AS, Austin PC. Evaluating early repeat emergency department use in patients with atrial fibrillation: a population-based analysis. Am Heart J. 2013 Jun; 165(6):939-48.
[6]	Boiarintsev VV, Alekseeva LA, Stazhadze LL, Bulanova NA, Bazarova MB, Mikhaĭlovskaia IV. [Atrial fibrillation registered for the first time: characteristics of clinical course, treatment, prognosis]. Kardiologiia. 2013; 53(2):25-9.
[7]	Atzema CL, Austin PC, Chong AS, Dorian P. Factors associated with 90-day death after emergency department discharge for atrial fibrillation. Ann Emerg Med. 2013 May; 61(5):539-548.e1.
[8]	Ball J, Carrington MJ, Wood KA, Stewart S; SAFETY Investigators. Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). PLoS One. 2013 May 29; 8(5):e65795.
[9]	Bhusri S, Ansell J. New anticoagulants in atrial fibrillation: an update for clinicians. Ther Adv Chronic Dis. 2012 Jan; 3(1):37-45.
[10]	Salhadin P, Bran M, De Marneffe M, Denolin H. Management of patients with chronic atrial fibrillation. Br J Clin Pharmacol. 1982; 13(Suppl 2):295S-296S.
[11]	Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, Brodsky M, Barrell P, Greene HL. Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol. 2005 Jun 21; 45(12):2026-33.
[12]	Rovellini A, Folli C, Cardani F, Monzani V. Thromboembolic and haemorrhagic events in permanent atrial fibrillation: observational study in an emergency department. Eur J Intern Med. 2009 Dec; 20(8):756-9.
[13]	Ki CS, Jung CL, Kim HJ, Baek KH, Park SJ, On YK, Kim KS, Noh SJ, Youm JB, Kim JS, Cho H. A KCNQ1 mutation causes age-dependant bradycardia and persistent atrial fibrillation. Pflügers Arch. 2013 Aug 30. [Epub ahead of print].
[14]	Lemmens R, Hermans S, Nuyens D, Thijs V. Genetics of atrial fibrillation and possible implications for ischemic stroke. Stroke Res Treat. 2011; 2011:208694.
[15]	Conway DS, Lip GY. Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project). Am J Cardiol. 2003 Dec 15; 92(12):1476-9.
[16]	Bosch RF, Pittrow D, Beltzer A, Kruck I, Kirch W, Kohlhaussen A, Bonnemeier H. Gender differences in patients with atrial fibrillation. Herzschrittmacherther Elektrophysiol. 2013 Sep; 24(3):176-183.
[17]	Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrillation: Ten years later. Gend Med. 2010 Jun; 7(3):206-17.
[18]	Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Lip GY, Larsen TB. Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med. 2013 Jul; 126(7):640.e9-17.
[19]	Zhuang J, Lu Y, Tang K, Peng W, Xu Y. Influence of body mass index on recurrence and quality of life in atrial fibrillation patients after catheter ablation: a meta-analysis and systematic review. Clin Cardiol. 2013 May; 36(5):269-75.
[20]	Guijian L, Jinchuan Y, Rongzeng D, Jun Q, Jun W, Wenqing Z. Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies. Pacing Clin Electrophysiol. 2013 Jun; 36(6):748-56.
[21]	Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med. 2010 Jul; 123(7):646-51.
[22]	Crystal E, Connolly SJ. Atrial fibrillation: guiding lessons from epidemiology. Cardiol Clin. 2004 Feb; 22(1):1-8.
[23]	Iguchi Y, Kimura K, Shibazaki K, Aoki J, Sakai K, Sakamoto Y, Uemura J, Yamashita S. HbA1c and atrial fibrillation: a cross-sectional study in Japan. Int J Cardiol. 2012 Apr 19; 156(2):156-9.
[24]	Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Petterson TM, O'Fallon WM, Gentile F, Spittell PC, Whisnant JP, Wiebers DO, Covalt JL, Seward JB. Association of atrial fibrillation and aortic atherosclerosis: a population-based study. Mayo Clin Proc. 2001 Mar; 76(3):252-9.
[25]	Potpara TS, Polovina MM, Licina MM, Mujovic NM, Marinkovic JM, Petrovic M, Vujisic-Tesic B, Lip GY. The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project. Int J Clin Pract. 2011 Nov; 65(11):1202-3.
[26]	Lévy S. Factors predisposing to the development of atrial fibrillation. Pacing Clin Electrophysiol. 1997 Oct; 20(10 Pt 2):2670-4.
[27]	Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, Faber J, Hansen PR, Pedersen OD, Torp-Pedersen C, Gislason GH. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012 Nov 27; 345:e7895.